Original Research

Published on 20 Nov 2024

Prediction of benign and malignant pulmonary nodules using preoperative CT features: using PNI-GARS as a predictor

in Cancer Immunity and Immunotherapy

Yuxin Zhan
Feipeng Song
Wenjia Zhang
Tong Gong
Shuai Zhao
Fajin Lv

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446511

143 views

Correction

Published on 20 Nov 2024

Corrigendum: Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Zhihong Zhao
Jian Ruan
Minjie Fang
Jingwen Liu
Guixiang Liao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1524791

Original Research

Published on 20 Nov 2024

A comprehensive nomogram for assessing the prognosis of non-small cell lung cancer patients receiving immunotherapy: a prospective cohort study in China

in Cancer Immunity and Immunotherapy

Hongmei Li
Yuliang Yuan
Qianjie Xu
Guangzhong Liang
Zuhai Hu
Xiaosheng Li
Wei Zhang
Haike Lei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487078

245 views

Review

Published on 20 Nov 2024

Immunome profiling in prostate cancer: a guide for clinicians

in Cancer Immunity and Immunotherapy

Luis San-Jose Manso
Arantzazu Alfranca
Ignacio Moreno-Pérez
María Ruiz-Vico
Clara Velasco
Patricia Toquero
María Pacheco
Almudena Zapatero
Diego Aldave
Guillermo Celada

Frontiers in Immunology

doi 10.3389/fimmu.2024.1398109

216 views

Original Research

Accepted on 19 Nov 2024

Identification of SPP1+ macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics

in Cancer Immunity and Immunotherapy

Han Jin
Woonghee Kim
Meng Yuan
Xiangyu Li
Hong Yang
Mengzhen Li
Mengnan Shi
HASAN TURKEZ
Mathias Uhlen
Cheng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446453

Brief Research Report

Accepted on 19 Nov 2024

Re-exposition to Ipilimumab plus Nivolumab in metastatic Merkel cell carcinoma

in Cancer Immunity and Immunotherapy

Valerie Glutsch
Patrick Schummer
Matthias Goebeler
Anja Gesierich
Bastian Schilling

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495004

105 views

Original Research

Accepted on 19 Nov 2024

Cross-Disease Transcriptomic Analysis Reveals DOK3 and PAPOLA as Therapeutic Targets for Neuroinflammatory and Tumorigenic Processes

in Cancer Immunity and Immunotherapy

Xingqiao Wang
Yusong Bian
Weiguang Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1504629

Original Research

Accepted on 19 Nov 2024

Exploring the Heterogeneity of Osteosarcoma Cell Characteristics and Metabolic States and Their Association with Clinical Prognosis

in Cancer Immunity and Immunotherapy

Sen Qin
Yaofeng Hu
Rucui Deng
Zhe Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507476

Editorial

Accepted on 19 Nov 2024

Editorial: Investigating tumor immunotherapy responses in lung cancer using deep learning

in Cancer Immunity and Immunotherapy

Shuang Qin
Haoxiang Zhang
Chao Liu
Ming Yi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1529949

131 views

Review

Published on 19 Nov 2024

Biological characteristics and immune responses of NK Cells in commonly used experimental mouse models

in Cancer Immunity and Immunotherapy

Jingwen Qin
Zhaokai Zhang
Haopeng Cui
Jinhua Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478323

189 views

Original Research

Published on 19 Nov 2024

Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study

in Cancer Immunity and Immunotherapy

Xiaobin Chen
Qindong Cai
Lin Deng
Minyan Chen
Min Xu
Lili Chen
Yuxiang Lin
Yan Li
Yali Wang
Hanxi Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1465862

201 views

Original Research

Published on 19 Nov 2024

Efficacy and safety of atezolizumab–bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study

in Cancer Immunity and Immunotherapy

Zili Hu
Zhoutian Yang
Zibo Fu
Yizhen Fu
Zeliang Ma
Zhongguo Zhou
Minshan Chen
Yaojun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1472870

206 views

Review

Published on 19 Nov 2024

Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?

in Cancer Immunity and Immunotherapy

Jun Zou
Baisheng Xu
Peiyue Luo
Tao Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482765

154 views

Original Research

Published on 19 Nov 2024

Machine learning-informed liquid-liquid phase separation for personalized breast cancer treatment assessment

in Cancer Immunity and Immunotherapy

Tao Wang
Shu Wang
Zhuolin Li
Jie Xie

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485123

210 views

Original Research

Accepted on 18 Nov 2024

Integrative multi-omics analysis reveals a novel subtype of hepatocellular carcinoma with biological and clinical relevance

in Cancer Immunity and Immunotherapy

Shizhou Li
Yan Lin
Xing Gao
Dandan Zeng
Weijie Cen
Yuejiao Su
Jingting Su
Can Zeng
Zhenbo Huang
Haoyu Zeng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1517312

125 views

Editorial

Accepted on 18 Nov 2024

Editorial: Immune Cell Exhaustion: New Challenges and Opportunities in Cancer Therapy

in Cancer Immunity and Immunotherapy

Hao Chi
Lai Jiang
Xuancheng Zhou
Lexin Wang
Guanhu Yang
Honghao Luo
Xiaoli Liu
Ke Xu
Gang Tian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1527428

Navigation group

Articles

Prediction of benign and malignant pulmonary nodules using preoperative CT features: using PNI-GARS as a predictor

Corrigendum: Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis

A comprehensive nomogram for assessing the prognosis of non-small cell lung cancer patients receiving immunotherapy: a prospective cohort study in China

Immunome profiling in prostate cancer: a guide for clinicians

Identification of SPP1+ macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics

Re-exposition to Ipilimumab plus Nivolumab in metastatic Merkel cell carcinoma

Cross-Disease Transcriptomic Analysis Reveals DOK3 and PAPOLA as Therapeutic Targets for Neuroinflammatory and Tumorigenic Processes

Exploring the Heterogeneity of Osteosarcoma Cell Characteristics and Metabolic States and Their Association with Clinical Prognosis

Editorial: Investigating tumor immunotherapy responses in lung cancer using deep learning

Biological characteristics and immune responses of NK Cells in commonly used experimental mouse models

Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study

Efficacy and safety of atezolizumab–bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study

Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?

Machine learning-informed liquid-liquid phase separation for personalized breast cancer treatment assessment

Integrative multi-omics analysis reveals a novel subtype of hepatocellular carcinoma with biological and clinical relevance

Editorial: Immune Cell Exhaustion: New Challenges and Opportunities in Cancer Therapy